If you follow the standard titration, one 10 mg vial provides: Phase 1 (weeks 1 to 4 at 0.25 mg): uses 1 mg Phase 2 (weeks 5 to 8 at 0.5 mg): uses 2 mg Phase 3 (weeks 9 to 12 at 1.0 mg): uses 4 mg Total through 12 weeks: 7 mg used, 3 mg remaining Remaining 3 mg covers about 1.5 to 2 more weeks at 1.7 mg One vial
Minimize the number of needle punctures through the stopper Refrigeration is non-negotiable after reconstitution
This pattern prevailed for each major milestone
Ozempic, Wegovy, and Rybelsus are the only FDA-approved products containing semaglutide produced by Novo Nordisk, Inc., while Zepbound and Mounjaro are the only FDA-approved products containing tirzepatide produced by Lilly USA LLC.
The dual GLP-1/GIP mechanism creates potent metabolic effects at lower doses than single-target agonists
For those using Semaglutide GLP-1 for diabetes management , improvements in glucose control may appear within days, while weight management benefits generally become more noticeable over several weeks
